Vitrolife AB (publ)
STO: VITR.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Bronwyn Brophy O'Connor
- Employees
- 1,150
- Headquarters
- Gothenburg, Sweden
- IPO year
- 2001
- Market cap
- SEK 14.6B
- Website
- https://www.vitrolife.com
Loading VITR…
Loading profile data…Frequently asked questions about VITR
What does Vitrolife AB (publ) (VITR.ST) do?
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers E...
Where does VITR.ST trade?
Vitrolife AB (publ) (VITR.ST) trades on the Stockholm Stock Exchange.
What sector is VITR.ST in?
Vitrolife AB (publ) (VITR.ST) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Vitrolife AB (publ)?
Bronwyn Brophy O'Connor is the chief executive officer of Vitrolife AB (publ) (VITR.ST).
Where is Vitrolife AB (publ) headquartered?
Vitrolife AB (publ) is headquartered in Sweden.
Does VITR.ST pay a dividend?
Yes — Vitrolife AB (publ) (VITR.ST) paid a trailing twelve-month dividend of SEK 1.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did VITR.ST go public?
Vitrolife AB (publ) (VITR.ST) completed its initial public offering in 2001.